课题基金 / 基金详情

DIFFERENTIATION OF MEDULLARY THYROID CARCINOMA CELLS

DIFFERENTIATION OF MEDULLARY THYROID CARCINOMA CELLS
甲状腺髓样癌细胞的分化
批准号:
3191143
负责人:
BARRY D. NELKIN
金额:
$19.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-04-01 至 1991-03-31

项目摘要

项目成果

BARRY D. NELKIN的其他基金

相似基金

相关文献

中文摘要
翻译
这个应用程序是我们实验室整体努力的一部分,
英文摘要
This application is part of an overall effort of our laboratory, which seeks to elucidate the control of neuroendocrine differentiation in normal thyroid C-cells and their neoplastic counterpart, medullary thyroid carcinoma (MTC). Understanding this control will provide a grasp of what functions may be altered in tumor developement and progression. Medullary thyroid carcinoma is a good model for this study, since defined stages of progression can be identified. We have defined an in vitro system to study these steps of MTC differentiation and progression. MTC cells in culture can be differentiated with respect to many characteristics of normal C- cells, either chemically or by ras oncogene introduction. Differentiation in turn can be blocked by myc oncogene introduction. The current Proposal will further characterize these findings, by cell biology, biochemistry, and molecular biology, concentrating on mechanisms of differentiation. 1. The effects of normal and activated cellular rasH oncogenes on MTC cell differentiation will be investigated, to determine whether the effect is specific to viral rasH. The effects of rasH on CT gene transcription will be ascertained. The effects of the myc oncogen on TT cells, and on ras induced differentiation, will be characterized. Finally, the effects of blocking endogenous c- rasH and c-myc expression will be investigated, using antisense RNA. 2. The biochemical pathway of ras-induced differentiation and myc blocking of differentiation in MTC cells will be studied, by assaying several enzymes and messengers in signal transduction pathways. Identifying alterations in these pathways in differentiated cells, or in cells blocked in differentiation, will be important in defining the processses controlling neuroendocrine differentiation. 3. The DNA sequences controlling ras mediated induction of CT gene expression will be defined, and compared to sequences involved in TPA or cAMP induced CT gene expression, using gene transfer and DNA binding assays. These same assays, along with DNA affinity chromatography, will then be used to partially purify a relevant DNA binding protein involved in ras mediated CT gene induction. This study will be important in elucidating the mechanisms of ras function in cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPLOITATION OF RET INHIBITORS FOR TREATMENT OF THYROID CANCER
  • 批准号:
    7300571
  • 项目类别:
  • 资助金额:
    $29.54万
  • 财政年份:
    2007
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
The Role of CDK5 in Metastasis
  • 批准号:
    7798576
  • 项目类别:
  • 资助金额:
    $35.05万
  • 财政年份:
    2001
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
Ras/raf/rho in Lung Cancer Growth and Differentiation
  • 批准号:
    6633658
  • 项目类别:
  • 资助金额:
    $33.93万
  • 财政年份:
    2001
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
The Role of CDK5 in Metastasis
  • 批准号:
    7367520
  • 项目类别:
  • 资助金额:
    $35.05万
  • 财政年份:
    2001
  • 负责人:
    BARRY D. NELKIN
  • 依托单位:
海外基金